These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6183657)

  • 21. [Comparison of natural and synthetic ligands for determining androgen receptors in prostatic tumors and prostatic nodular hyperplasia].
    Kushlinskiĭ NR; Bassalyk LS; Degtiar' VG
    Med Radiol (Mosk); 1983 Aug; 28(8):13-6. PubMed ID: 6193390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study of binding, metabolism and endogenous levels of androgens in normal, hyperplastic and carcinomatous human prostate.
    Krieg M; Bartsch W; Janssen W; Voigt KD
    J Steroid Biochem; 1979 Jul; 11(1B):615-24. PubMed ID: 90754
    [No Abstract]   [Full Text] [Related]  

  • 23. Interaction of digitalis and spironolactone with human sex steroid receptors.
    Rifka SM; Pita JC; Vigersky RA; Wilson YA; Loriaux DL
    J Clin Endocrinol Metab; 1978 Feb; 46(2):338-44. PubMed ID: 86546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Properties of androphilic proteins in cytosols of human benign prostatic hypertrophy.
    Kodama T; Shimazaki J
    Endocrinol Jpn; 1979 Aug; 26(4):449-58. PubMed ID: 91507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative binding specificity of methyltrienolone in human and rat prostate.
    Dubé JY; Chapdelaine P; Tremblay RR; Bonne C; Raynaud JP
    Horm Res; 1976; 7(6):341-7. PubMed ID: 69599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlations between DHT levels and NBS of R1881 receptor in total tissue, cytosol and nuclear extract of human prostate].
    Morioka M; Ohashi Y; Fujita Y; Takeda K; Tojo S; Ohashi T; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1984 Jan; 75(1):96-103. PubMed ID: 6204091
    [No Abstract]   [Full Text] [Related]  

  • 27. Characterization of the binding of a potent synthetic androgen, methyltrienolone, to human tissues.
    Menon M; Tananis CE; Hicks LL; Hawkins EF; McLoughlin MG; Walsh PC
    J Clin Invest; 1978 Jan; 61(1):150-62. PubMed ID: 73547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgen binding in cytosols and nuclei of human benign hyperplastic prostatic tissue.
    Sirett DA; Grant JK
    J Endocrinol; 1978 Apr; 77(1):101-10. PubMed ID: 76668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subcellular distribution of zinc in the benign and malignant human prostate: evidence for a direct zinc androgen interaction.
    Leake A; Chrisholm GD; Busuttil A; Habib FK
    Acta Endocrinol (Copenh); 1984 Feb; 105(2):281-8. PubMed ID: 6198862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human prostatic carcinoma: significant differences in its androgen binding and metabolism compared to the human benign prostatic hypertrophy.
    Krieg M; Grobe I; Voight KD; Altenähr E; Klosterhalfen H
    Acta Endocrinol (Copenh); 1978 Jun; 88(2):397-407. PubMed ID: 78653
    [No Abstract]   [Full Text] [Related]  

  • 31. Androgen receptor assay in human benign and malignant prostatic tumour cytosol using protamine sulphate precipitation.
    Mobbs BG; Johnson IE; Connolly JG; Clark AF
    J Steroid Biochem; 1978 Apr; 9(4):289-301. PubMed ID: 77938
    [No Abstract]   [Full Text] [Related]  

  • 32. Characterization of different forms of the androgen receptor.
    Lea OA; Wilson EM; French FS
    Endocrinology; 1979 Dec; 105(6):1350-60. PubMed ID: 499078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostatic tissue distribution of 17 beta-hydroxy-5 alpha-androstan-3-one and of androgen receptors in benign hyperplasia.
    Sirett DA; Cowan SK; Janeczko AE; Grant JK; Glen ES
    J Steroid Biochem; 1980 Jul; 13(7):723-8. PubMed ID: 6157942
    [No Abstract]   [Full Text] [Related]  

  • 34. Measurement of androgen receptor in cytosol of human prostatic tissues with a sepharose-linked antibody system.
    Kliman B; MacLaughlin RA; Prout GR
    Prog Clin Biol Res; 1979; 33():85-96. PubMed ID: 93753
    [No Abstract]   [Full Text] [Related]  

  • 35. Androgen and estrogen receptors in brain cytosol from male, female, and testicular feminized (tfm/y hermaphrodite) mice.
    Attardi B; Geller LN; Ohno S
    Endocrinology; 1976 Apr; 98(4):864-74. PubMed ID: 179788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hormone-dependency of the human prostate].
    Robel P
    Bull Cancer; 1986; 73(1):19-22. PubMed ID: 2430651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Studies on the androgen-binding proteins in human benign prostatic hypertrophy].
    Tomioka O
    Hinyokika Kiyo; 1983 Mar; 29(3):267-85. PubMed ID: 6203381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steroid receptors in the human prostate. Detection of tissue-specific androgen binding in prostate cancer.
    Hawkins EF; Nijs M; Brassinne C
    Clin Chim Acta; 1977 Mar; 75(2):303-12. PubMed ID: 844208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dihydrotestosterone-binding protein in cytosols of normal and hypertrophic human prostates, and influence of estrogens and anti-androgens on the binding.
    Shimazaki J; Kodama T; Wakisaka M; Katayama T
    Endocrinol Jpn; 1977 Feb; 24(1):9-14. PubMed ID: 67940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low molecular weight component of androgen receptor in cytosols from benign hypertrophic human prostate treated with high KCl solution.
    Kodama T; Fuse H; Shimazaki J
    Endocrinol Jpn; 1982 Jun; 29(3):325-33. PubMed ID: 6184218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.